Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(3): 696-704. doi: 10.34172/apb.2024.045
PMID: 39494251        PMCID: PMC11530872

Research Article

Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment

Saeid Amiri Zadeh Fard 1,2 ORCID, Haniyeh Abuei 3 ORCID, Abbas Behzad Behbahani 1 ORCID, Gholamreza Rafiei Dehbidi 1 ORCID, Farahnaz Zare 1 ORCID, Maryam Nejabat 4 ORCID, Alireza Safarpour 2 ORCID, Ali Farhadi 1 * ORCID

Cited by CrossRef: 1

1- Pan C, Lee L. Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(2):189272 [Crossref]
2- Faghirabadi F, Abuei H, Malekzadeh M, Mojiri A, Farhadi A. Intracellular delivery of antiviral shRNA using penetratin-based complexes effectively inhibits respiratory syncytial virus replication and host cell apoptosis. Virol J. 2024;21(1) [Crossref]
3- Xiang J, Xu J, Zhu J, Yang B, Wan M, Cai J, Chen S, Wang Y, Yang S, Wang Y, Lin L, Zhang Q, Zang N, Liu E, Wan Y. Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice. Molecular Therapy. 2026; [Crossref]